Glucagon-like peptide 1 (GLP-1) receptor agonists are a group of medications used for the treatment of type 2 diabetes mellitus and for producing weight loss in obese and (some) overweight persons. They are increasingly being used to treat these conditions and, specifically, to treat weight gain associated with second-generation antipsychotics. For our articles about GLP-1…